3692:HKG
Hansoh Pharmaceutical Group Company Ltd
31,74 HKD
arrow_upward
+1,15%(+0,36) 1 D
16. okt., 16:08:14 GMT+8 · HKD
search
Alle symboler
| Symbol | Pris | Endring | Endring (%) |
|---|
insights_autoGenererer viktig statistikk for 3692 …
Åpne
31,72 HKD
Høy
32,44 HKD
Lav
31,52 HKD
Markedsverdi
192,48 mrd.
Snittvolum
8,58 mill.
Volum
10,50 mill.
Utbytte
1,53 %
Kvartalsvis utbytte
0,12 HKD
Første dato etter utbytte
22. sep. 2026
P/E-forhold
24,51
52 u høy
44,22 HKD
52 u lav
28,06 HKD
EPS
1,30 HKD
Antall ansatte
10k
Åpne
31,72 HKD
Høy
32,44 HKD
Lav
31,52 HKD
Markedsverdi
192,48 mrd.
Snittvolum
8,58 mill.
Volum
10,50 mill.
Utbytte
1,53 %
Kvartalsvis utbytte
0,12 HKD
Første dato etter utbytte
22. sep. 2026
P/E-forhold
24,51
52 u høy
44,22 HKD
52 u lav
28,06 HKD
EPS
1,30 HKD
Antall ansatte
10k
Nyhetssaker
Fra nettkilder og nyhetspartnere
ad-hoc-news.de
·
for 13 minutter siden
Hansoh Pharma stock gets HKD 47.82 consensus target
Simply Wall Street
·
for 25 minutter siden
Could EMA Review Alter The Investment Case For Hansoh Pharma Stock (SEHK:3692)?
Profil
Hansoh Pharmaceutical Group Company Limited is a pharmaceutical company that manufactures and sells various types of medicine in mainland China. It was founded in 1995 in Lianyungang, Jiangsu Province, China, by Zhong Huijuan, who is the company's chair. Zhong and her family own 66% of the company. It is the largest psychotropic drug producer in China.
Hansoh Pharmaceutical had an initial public offering on the main board of the Hong Kong Stock Exchange on 14 June 2019.
In August 2022, it was announced that the company's stock would be added to the Hang Seng Index. Wikipedia
Om Hansoh Pharmaceutical Group Company Ltd